Publicaciones en las que colabora con Raquel Vázquez Mourelle (8)

2022

  1. Impact on In- and Out-of-Hospital Drug Prescriptions of Including a More Expensive Me-Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study

    Pharmacoepidemiology and Drug Safety, Vol. 31, Núm. 5, pp. 556-565

2020

  1. Impact of a change of bronchodilator medications in a hospital drug formulary on intra- A nd out-of-hospital drug prescriptions: Interrupted time series design with comparison group

    Implementation Science, Vol. 15, Núm. 1

  2. Impact of a health alert and its implementation on flutamide prescriptions for women: an interrupted time series analysis

    BMC health services research, Vol. 20, Núm. 1, pp. 597

2019

  1. Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group

    Implementation science : IS, Vol. 14, Núm. 1, pp. 75

2018

  1. Impact of Health Authority Control Measures Aimed at Reducing the Illicit Use of Anabolic-Androgenic Steroids

    European Addiction Research, Vol. 24, Núm. 1, pp. 28-36

2017

  1. The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors

    Farmacia Hospitalaria, Vol. 41, Núm. 1, pp. 49-67

2016

  1. Eficiencia del programa de seguimiento farmacoterapéutico de antipsicóticos parenterales de acción prolongada en el área sanitaria de Santiago de Compostela

    Gaceta Sanitaria, Vol. 30, Núm. 1, pp. 73-76

2015

  1. Control measures for anabolic androgenic steroid medicines

    Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 304-307